| JSJFX | VISGX | JSJFX / VISGX | |
| Total Expense Ratio | 0.84 | 0.19 | 442% |
| Annual Report Gross Expense Ratio | 0.99 | 0.19 | 521% |
| Fund Existence | 8 years | 28 years | - |
| Gain YTD | -5.413 | 10.818 | -50% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 3000 | 33,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 519M | 39.7B | 1% |
| Annual Yield % from dividends | 3.18 | 0.43 | 734% |
| Returns for 1 year | -7.29 | 8.50 | -86% |
| Returns for 3 years | 25.17 | 55.60 | 45% |
| Returns for 5 years | -28.26 | 14.70 | -192% |
| Returns for 10 years | N/A | 157.20 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMED | 27.61 | 0.10 | +0.38% |
| Fidelity Disruptive Medicine ETF | |||
| QQQX | 28.51 | 0.10 | +0.35% |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | |||
| THNQ | 64.86 | 0.01 | +0.02% |
| Robo Global® Artificial Intelligence ETF | |||
| LAYS | 52.29 | -0.11 | -0.20% |
| STKd 150% NVDA & 150% AMD ETF | |||
| OKLL | 21.69 | -0.38 | -1.74% |
| Defiance Daily Target 2X Long OKLO ETF | |||